BIO Net Receivables vs Current Deferred Revenue Analysis

Stocks . USA . 
Stock . BIO Key International
BKYI Stock  USD 1.07  0.03  2.73%   
BIO Key financial indicator trend analysis is way more than just evaluating BIO Key International prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether BIO Key International is a good investment. Please check the relationship between BIO Key Net Receivables and its Current Deferred Revenue accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BIO Key International. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing.

Net Receivables vs Current Deferred Revenue

Net Receivables vs Current Deferred Revenue Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of BIO Key International Net Receivables account and Current Deferred Revenue. At this time, the significance of the direction appears to have almost no relationship.
The correlation between BIO Key's Net Receivables and Current Deferred Revenue is 0.13. Overlapping area represents the amount of variation of Net Receivables that can explain the historical movement of Current Deferred Revenue in the same time period over historical financial statements of BIO Key International, assuming nothing else is changed. The correlation between historical values of BIO Key's Net Receivables and Current Deferred Revenue is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Receivables of BIO Key International are associated (or correlated) with its Current Deferred Revenue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Current Deferred Revenue has no effect on the direction of Net Receivables i.e., BIO Key's Net Receivables and Current Deferred Revenue go up and down completely randomly.

Correlation Coefficient

0.13
Relationship DirectionPositive 
Relationship StrengthInsignificant

Net Receivables

Current Deferred Revenue

Revenue that has been collected but not yet earned, typically from prepaid service contracts or subscriptions. This amount is considered a liability until the service is provided or the subscription period ends.
Most indicators from BIO Key's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into BIO Key International current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BIO Key International. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing.
The BIO Key's current Tax Provision is estimated to increase to about 128.5 K, while Selling General Administrative is projected to decrease to under 5.1 M.
 2021 2022 2023 2024 (projected)
Interest Expense18K30.0K218.3K207.4K
Depreciation And Amortization514.1K546.0K590.1K573.1K

BIO Key fundamental ratios Correlations

Total Assets
Short Long Term Debt Total
Other Current Liab
Total Current Liabilities
Total Stockholder Equity
Property Plant And Equipment Net
Net Debt
Retained Earnings
Accounts Payable
Cash
Non Current Assets Total
Non Currrent Assets Other
Cash And Short Term Investments
Common Stock Total Equity
Common Stock Shares Outstanding
Inventory
Other Current Assets
Other Stockholder Equity
Total Liab
Property Plant And Equipment Gross
Total Current Assets
Short Term Debt
Common Stock
Net Receivables
Non Current Liabilities Total
Other Assets
Total Assets
0.240.16-0.020.990.24-0.68-0.29-0.110.670.75-0.270.66-0.50.330.380.590.47-0.06-0.110.89-0.06-0.520.65-0.370.39
Short Long Term Debt Total
0.24-0.150.030.230.010.220.130.01-0.20.48-0.28-0.2-0.20.48-0.080.48-0.09-0.06-0.37-0.020.23-0.110.35-0.410.33
Other Current Liab
0.16-0.150.610.060.290.16-0.670.35-0.110.250.05-0.11-0.680.140.37-0.060.640.610.510.080.11-0.750.32-0.310.26
Total Current Liabilities
-0.020.030.61-0.160.550.24-0.680.72-0.09-0.11-0.02-0.08-0.56-0.250.39-0.050.60.960.490.070.77-0.590.14-0.15-0.16
Total Stockholder Equity
0.990.230.06-0.160.15-0.7-0.18-0.210.660.76-0.260.65-0.410.370.320.60.37-0.2-0.190.86-0.18-0.430.63-0.350.41
Property Plant And Equipment Net
0.240.010.290.550.15-0.37-0.610.050.51-0.11-0.230.53-0.48-0.340.26-0.270.580.560.470.410.53-0.5-0.190.11-0.14
Net Debt
-0.680.220.160.24-0.7-0.370.230.35-0.98-0.130.14-0.980.190.11-0.16-0.06-0.350.2-0.01-0.860.190.19-0.080.040.04
Retained Earnings
-0.290.13-0.67-0.68-0.18-0.610.23-0.42-0.3-0.050.19-0.30.83-0.07-0.490.13-0.98-0.74-0.75-0.42-0.290.84-0.210.350.14
Accounts Payable
-0.110.010.350.72-0.210.050.35-0.42-0.29-0.10.01-0.29-0.290.00.110.250.330.630.35-0.090.44-0.350.31-0.21-0.3
Cash
0.67-0.2-0.11-0.090.660.51-0.98-0.3-0.290.08-0.151.0-0.24-0.20.230.00.4-0.070.050.87-0.01-0.240.030.0-0.08
Non Current Assets Total
0.750.480.25-0.110.76-0.11-0.13-0.05-0.10.08-0.210.07-0.440.610.10.680.2-0.16-0.20.37-0.24-0.470.71-0.460.77
Non Currrent Assets Other
-0.27-0.280.05-0.02-0.26-0.230.140.190.01-0.15-0.21-0.150.11-0.09-0.16-0.15-0.24-0.06-0.19-0.25-0.070.09-0.19-0.21-0.02
Cash And Short Term Investments
0.66-0.2-0.11-0.080.650.53-0.98-0.3-0.291.00.07-0.15-0.24-0.210.220.00.4-0.060.060.870.0-0.250.010.01-0.08
Common Stock Total Equity
-0.5-0.2-0.68-0.56-0.41-0.480.190.83-0.29-0.24-0.440.11-0.24-0.38-0.36-0.14-0.86-0.55-0.43-0.43-0.170.97-0.440.71-0.28
Common Stock Shares Outstanding
0.330.480.14-0.250.37-0.340.11-0.070.0-0.20.61-0.09-0.21-0.380.030.440.14-0.29-0.20.04-0.36-0.340.55-0.650.29
Inventory
0.38-0.080.370.390.320.26-0.16-0.490.110.230.1-0.160.22-0.360.03-0.090.510.330.020.460.42-0.370.15-0.09-0.02
Other Current Assets
0.590.48-0.06-0.050.6-0.27-0.060.130.250.00.68-0.150.0-0.140.44-0.090.01-0.11-0.230.36-0.13-0.160.88-0.40.24
Other Stockholder Equity
0.47-0.090.640.60.370.58-0.35-0.980.330.40.2-0.240.4-0.860.140.510.010.670.690.570.21-0.870.35-0.4-0.04
Total Liab
-0.06-0.060.610.96-0.20.560.2-0.740.63-0.07-0.16-0.06-0.06-0.55-0.290.33-0.110.670.660.070.66-0.60.11-0.1-0.22
Property Plant And Equipment Gross
-0.11-0.370.510.49-0.190.47-0.01-0.750.350.05-0.2-0.190.06-0.43-0.20.02-0.230.690.660.050.06-0.470.00.08-0.3
Total Current Assets
0.89-0.020.080.070.860.41-0.86-0.42-0.090.870.37-0.250.87-0.430.040.460.360.570.070.050.06-0.440.45-0.210.01
Short Term Debt
-0.060.230.110.77-0.180.530.19-0.290.44-0.01-0.24-0.070.0-0.17-0.360.42-0.130.210.660.060.06-0.16-0.120.14-0.27
Common Stock
-0.52-0.11-0.75-0.59-0.43-0.50.190.84-0.35-0.24-0.470.09-0.250.97-0.34-0.37-0.16-0.87-0.6-0.47-0.44-0.16-0.450.62-0.3
Net Receivables
0.650.350.320.140.63-0.19-0.08-0.210.310.030.71-0.190.01-0.440.550.150.880.350.110.00.45-0.12-0.45-0.540.22
Non Current Liabilities Total
-0.37-0.41-0.31-0.15-0.350.110.040.35-0.210.0-0.46-0.210.010.71-0.65-0.09-0.4-0.4-0.10.08-0.210.140.62-0.54-0.31
Other Assets
0.390.330.26-0.160.41-0.140.040.14-0.3-0.080.77-0.02-0.08-0.280.29-0.020.24-0.04-0.22-0.30.01-0.27-0.30.22-0.31
Click cells to compare fundamentals

BIO Key Account Relationship Matchups

High Positive Relationship

Cash And Short Term Investments
+ 1.0
Cash
Total Stockholder Equity
+ 0.99
Total Assets
Common Stock
+ 0.97
Common Stock Total Equity
Total Liab
+ 0.96
Total Current Liabilities
Total Current Assets
+ 0.89
Total Assets
Net Receivables
+ 0.88
Other Current Assets

High Negative Relationship

Other Stockholder Equity
- 0.98
Retained Earnings
Cash And Short Term Investments
- 0.98
Net Debt
Cash
- 0.98
Net Debt
Common Stock
- 0.87
Other Stockholder Equity
Other Stockholder Equity
- 0.86
Common Stock Total Equity
Total Current Assets
- 0.86
Net Debt

BIO Key fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets2.5M22.5M17.8M11.9M4.5M4.3M
Other Current Liab686.9K490.9K770.4K984.5K1.2M963.2K
Total Current Liabilities4.4M1.9M2.0M4.6M3.2M3.1M
Total Stockholder Equity(2.3M)20.3M15.6M7.1M1.1M1.0M
Property Plant And Equipment Net662.0K569.1K323.3K304.8K257.1K226.5K
Net Debt2.7M(16.3M)(7.5M)(414.1K)(146.1K)(138.8K)
Retained Earnings(89.7M)(99.5M)(104.6M)(114.8M)(125.0M)(118.8M)
Accounts Payable919.3K244.2K427.8K1.1M1.3M667.1K
Cash79.0K17.0M7.8M2.6M511.4K485.8K
Non Current Assets Total1.1M3.6M3.8M2.5M1.9M1.8M
Non Currrent Assets Other240.2K174.0K370.7K437.8K229.8K218.3K
Cash And Short Term Investments591.8K17.5M7.8M2.6M511.4K485.8K
Common Stock Total Equity769.01.4K1.4K782.0703.8668.61
Common Stock Shares Outstanding98.8K261.2K432.9K450.0K560.3K391.0K
Liabilities And Stockholders Equity2.5M22.5M17.8M11.9M4.5M4.3M
Inventory429.1K330.9K4.9M4.8M445.7K657.9K
Other Current Assets108.4K201.5K216.0K342.7K364.2K346.0K
Other Stockholder Equity87.4M119.8M120.2M122.0M126.0M132.4M
Total Liab4.8M2.2M2.2M4.9M3.5M4.7M
Property Plant And Equipment Gross662.0K569.1K323.3K304.8K1.4M1.4M
Total Current Assets1.4M18.9M14.0M9.4M2.6M5.0M
Short Term Debt2.4M466.3K177.2K2.9M176.6K167.7K
Common Stock1.4K782.0786.0919.0103.097.85
Net Receivables236.9K903.5K1.1M1.6M1.3M1.6M
Non Current Liabilities Total390.5K309.2K154.3K210.0K240.1K228.1K
Accumulated Other Comprehensive Income(690.5K)(772.3K)0.0(242.6K)22.8K24.0K
Other Assets240.2K174.0K370.7K1.00.90.86
Property Plant Equipment148.6K662.0K569.1K323.3K371.8K240.4K
Current Deferred Revenue359.2K657.3K565.4K462.4K415.0K394.2K
Intangible Assets228.2K1.6M1.3M1.8M1.4M2.6M
Deferred Long Term Liab319.2K231.5K165.3K249.0K286.4K248.3K
Net Tangible Assets3.5M(2.5M)17.5M13.0M14.9M15.7M
Capital Surpluse80.8M85.6M87.4M119.8M137.8M88.3M
Net Invested Capital(29.7K)20.6M15.6M9.1M1.4M1.3M

Currently Active Assets on Macroaxis

CCitigroup
GMGeneral Motors
FFord Motor
GMGeneral Motors
VVisa Class A
When determining whether BIO Key International offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of BIO Key's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Bio Key International Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Bio Key International Stock:
How To Invest In BIO
Details
Is BIO Stock a good investment?
Details
What is BIO Key's Net Worth?
Details
Largest Security & Protection Services Companies
View
Largest Information Technology Companies
View
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BIO Key International. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing.
You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Is Systems Software space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of BIO Key. If investors know BIO will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about BIO Key listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(8.66)
Revenue Per Share
6.323
Quarterly Revenue Growth
(0.41)
Return On Assets
(0.56)
Return On Equity
(4.58)
The market value of BIO Key International is measured differently than its book value, which is the value of BIO that is recorded on the company's balance sheet. Investors also form their own opinion of BIO Key's value that differs from its market value or its book value, called intrinsic value, which is BIO Key's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because BIO Key's market value can be influenced by many factors that don't directly affect BIO Key's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Altman
Z Score
Details
Piotroski
F Score
Details
Beneish
M Score
Details
Financial
Analysis
Details
Buy or Sell
Advice
Details
Earnings
Projections
Details
Please note, there is a significant difference between BIO Key's value and its price as these two are different measures arrived at by different means. Investors typically determine if BIO Key is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, BIO Key's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY